Recent Security Class Actions
Intersect ENT Inc. Common Stock (NASDAQ: XENT)
Company Name:Intersect ENT Inc. Common Stock
Stock Symbol:NASDAQ: XENT
Class Period Start:02/27/2018
Class Period End (inclusive):08/01/2019
Filing Deadline:07/14/2019
According to the Complaint, Intersect is a commercial drug delivery company that purports to develop products for patients with ear, nose, and throat conditions. The Company’s PROPEL family of products are used in conjunction with sinus surgery, and the Company’s SINUVA sinus implant is used to treat patients who have had surgery yet suffer from recurrent sinus obstruction due to polyps.
